Side-by-side financials for BCAB and BNTX. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | BCAB | BNTX |
|---|---|---|
| Market cap | - | $22.64 B |
| US-listed rank | - | #570 |
| Revenue (latest FY) | $300.00K | - |
| Net income (latest FY) | -$59.61M | - |
| Net margin | -19869.0% | - |
| SEC filings | 490 | 548 |
Full pages: BioAtla, Inc. and BioNTech SE, or browse the full rankings.